Alpha radionuclide-chelated radioimmunotherapy promoters enable local radiotherapy/chemodynamic therapy to discourage cancer progression

Biomaterials Research
September 8, 2022
Cited by 42


Related Papers

No related papers found

Powered by citation graph analysis